fbpx Skip to main content

Member's Profile

Cardiff Oncology

11055 Flintkote Ave
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2010
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Cardiff Oncology
Biotech Company
Cardiff Oncology (formerly Trovagene, Inc.) is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Our clinical development programs incorporate tumor genomics and biomarker technology to enable assessment of patient response to treatment.
Related News
Trovagene Announces Changing of Company Name to Cardiff Oncology and Appointment of Mark Erlander, PhD, as CEO
May 14, 2020
... Read more.